Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,873 | -1,249 | -464 | -2,399 | -2,067 |
| Depreciation Amortization | 2 | 2 | 1 | 2 | 2 |
| Accounts receivable | 232 | 222 | 85 | -176 | 11 |
| Other Working Capital | 400 | 299 | 179 | 235 | 389 |
| Other Operating Activity | -85 | -130 | -51 | 323 | 106 |
| Operating Cash Flow | $-1,324 | $-856 | $-250 | $-2,015 | $-1,559 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,973 | 720 | 350 | 2,000 | 1,750 |
| Financing Cash Flow | $1,973 | $720 | $350 | $2,000 | $1,750 |
| Beginning Cash Position | 409 | 409 | 409 | 424 | 424 |
| End Cash Position | 1,058 | 273 | 509 | 409 | 615 |
| Net Cash Flow | $649 | $-136 | $100 | $-15 | $191 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,324 | -856 | -250 | -2,015 | -1,559 |
| Free Cash Flow | -1,324 | -856 | -250 | -2,015 | -1,559 |